Interested in Connecting? Please contact: Michael Hite CEO email@example.com
Message the company or request a 1:1 meeting here.
Our device uses multi-sensor machine-learning to identify respiratory depression in opioid overdose, audibly alarm and wirelessly alert for help in real-time. We intend to become the new standard of care for Substance Use Disorder (SUD) patients. Parachute will be prescribed to patients at high-risk of overdose, potentially alongside naloxone. Parachute will be reimbursed by Medicare-Medicaid as a PMA medical device through FDA’s Breakthrough Device program. We intend to partner with remote patient monitoring firms to offer services to SUD providers (and a hardware + subscription option for patients’ families). We also intend to partner with SUD treatment networks to engage patients with services within 24h of an overdose event.